HCMC – One hour after starting the clinical trial of the Covid-19 vaccine produced by Nanogen Pharmaceutical Biotechnology JSC, a Vietnamese firm, as many as 30 volunteers signed up to participate in the trial, which took place at the Vietnam Military Medical Academy in Hanoi City today, December 10.
If the trial is successful, the vaccine will be available in the community by May next year.
Ho Nhan, chairman of Nanogen, said there were four dose levels for the injection of the vaccine, called Nanocovax, including 25 mcg, 50 mcg, 75 mcg and 100 mcg, Tuoi Tre Online reported.
After testing the vaccine on mice, hamsters, monkeys and rabbits, the results showed that the vaccine was safe.
Nhan also said the Covid-19 vaccine is similar to the seasonal influenza vaccine, which can protect people within six months and must be injected annually.
The firm has also produced the nasal spray Covid-19 vaccine for children under 12, the elderly and sick people.
As the vaccine is subsidized and ordered by the Government, each shot is priced at VND120,000, Nhan added.
Do Quyet, director of the Vietnam Military Medical Academy, which is in charge of organizing the trial, said that Vietnam is one of 40 countries in the world to test its Covid-19 vaccine on people.